openPR Logo
Press release

Autoimmune Disease Diagnostics Market to Advance at CAGR of 3.8% during 2019 - 2027: TMR Study

Autoimmune Disease Diagnostics

Autoimmune Disease Diagnostics

The latest research study released by Transparency Market Research on "๐€๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•โ€ณ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Autoimmune Disease Diagnosticsย  industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

Autoimmune Disease Diagnosticsย  market is estimated to attain a valuation of US$ 14.4 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3.8% during the forecast period, 2019 - 2027

๐†๐ž๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ-https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351

๐†๐ซ๐จ๐ฐ๐ข๐ง๐  ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ฆ๐จ๐ง๐  ๐๐ž๐จ๐ฉ๐ฅ๐ž ๐š๐›๐จ๐ฎ๐ญ ๐€๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ ๐๐จ๐จ๐ฌ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก

Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market

AARDA initiated the formation of the Center for Autoimmune Disease Research at Johns Hopkins University Medical Center and the NIH established Centers of Excellence in autoimmune diseases. AARDA also sponsors various programs and workshops aimed at bringing together researchers from different disciplines involved in autoimmune research. These factors are likely to fuel the growth of the market.

Rising awareness among people and increasing government initiatives are the major factors driving the autoimmune disease diagnostics market

๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐•๐ž๐ซ๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ:

Detailed industry forecast
Brief Introduction to the research report.
Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

๐„๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐  - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=5351

๐“๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐จ๐ฏ๐ž๐ซ๐ฌ ๐ž๐ฑ๐ญ๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ข๐ง๐ญ๐ž๐ฅ๐ฅ๐ข๐ ๐ž๐ง๐œ๐ž ๐ฐ๐ก๐ข๐œ๐ก ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐๐š๐ญ๐š ๐ฉ๐จ๐ข๐ง๐ญ๐ฌ:

- Business Overview

- Business Model

- Financial Data

- Financial - Existing

- Financial - Funding

- Product/Service Segment Analysis and specification

- Recent Development and Company Strategy Analysis

- SWOT Analysis

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

The significant players operating in the global Autoimmune Disease Diagnosticsย  market are

Abbott Laboratories, Inc., Beckman Coulter, Inc., bioMรฉrieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง -

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2019 - 2027.

๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฅ๐ž๐ญ๐ฌ ๐ฒ๐จ๐ฎ ๐ข๐๐ž๐ง๐ญ๐ข๐Ÿ๐ฒ ๐ญ๐ก๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐€๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌย  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐›๐ฒ ๐ฆ๐ž๐š๐ง๐ฌ ๐จ๐Ÿ ๐š ๐ซ๐ž๐ ๐ข๐จ๐ง:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

๐‡๐š๐ฏ๐ž ๐€๐ง๐ฒ ๐๐ฎ๐ž๐ซ๐ฒ? ๐€๐ฌ๐ค ๐“๐จ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=5351

๐†๐ฅ๐จ๐›๐š๐ฅ ๐€๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐Š๐ž๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ

Key players in the global autoimmune disease diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global autoimmune disease diagnostics market. A few expansion strategies adopted by players operating in the global autoimmune disease diagnostics market are:

In March 2019, Abbott received CE Mark for its Alinity m diagnostics system and assays. This new technology will help keep up with the growing demand for infectious disease testing.

In June 2016, Beckman Coulter Diagnostics announced that it is ramping up its commercial focus on the Indian subcontinent with a series of steps that will help substantially increase its customer base- small- to large-volume hospital pathology laboratories.

In February 2019, Roche have entered into a definitive merger agreement with Spark Therapeutics, Inc. at a price of US$ 114.50 per share in an all-cash transaction.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก -

๐’๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ž๐ญ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2022/08/22/2502370/0/en/Sports-Betting-Market-to-Rise-at-a-CAGR-of-9-8-during-Forecast-Period-2022-2031-notes-TMR-Study.html

๐๐ข๐จ๐›๐š๐ง๐ค๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2022/08/22/2502428/0/en/Value-of-Biobanking-Market-Estimated-at-US-87-4-Bn-by-2031-TMR-Study.html

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market to Advance at CAGR of 3.8% during 2019 - 2027: TMR Study here

News-ID: 3340906 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | Transparency Market Research
Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | โ€ฆ
The global methanol market was valued at US$ 22.0 billion in 2023 and is expected to witness steady expansion over the next decade. According to industry analysis, the market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2034, reaching an estimated US$ 32.9 billion by the end of 2034. This growth trajectory reflects the increasing relevance of methanol as a versatile chemicalโ€ฆ
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 Billion by 2034 at 5.5% CAGR | Transparency Market Research
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 โ€ฆ
The global Methanol-to-Olefins (MTO) market is witnessing a strong transformation as industries increasingly shift toward sustainable feedstocks and alternative non-petroleum chemical pathways. Valued at US$ 24.5 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 44.1 billion by the end of 2034. This growth trajectory highlights the strategic importance of MTO technology inโ€ฆ
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Industrial Growth to Propel Market at 5.1% CAGR | Transparency Market Research
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Indust โ€ฆ
The global methyl chloride market was valued at US$ 2.2 billion in 2023 and is poised for steady expansion over the coming decade. According to the latest industry outlook, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2035, reaching an estimated US$ 4.1 billion by the end of 2035. This sustained growth reflects the compound's critical role as a chemicalโ€ฆ
Global Methyl Ester Sulfonate Market to Reach USD 974.1 Mn by 2031, Driven by Rising Demand for Biodegradable Surfactants
Global Methyl Ester Sulfonate Market to Reach USD 974.1 Mn by 2031, Driven by Ri โ€ฆ
The global methyl ester sulfonate (MES) market was valued at US$ 656.7 Mn in 2022 and is projected to reach US$ 974.1 Mn by the end of 2031, expanding at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2031. This steady growth trajectory reflects the increasing shift toward biodegradable, plant-based surfactants across personal care, household cleaning, and industrial applications worldwide. Access an overview of significant conclusions from ourโ€ฆ

All 5 Releases


More Releases for Autoimmune

Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),โ€ฆ
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru โ€ฆ
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases. New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companiesโ€ฆ
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune โ€ฆ
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616 This latest report researches the industry structure,โ€ฆ
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre โ€ฆ
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attackingโ€ฆ
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto โ€ฆ
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants areโ€ฆ
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut โ€ฆ
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics includeโ€ฆ